Time matters – in vitro cellular disposition kinetics help rationalizing cellular potency disconnects

References

• Bednarczyk D, Sanghvi MV. 2020. The impact of assay recovery on the apparent permeability, a function of lysosomal trapping. Xenobiotica. 50(7):753–760.
   PubMed Web of Science ®Google Scholar
• Chu X, Korzekwa K, Elsby R, Fenner K, Galetin A, Lai Y, Matsson P, Moss A, Nagar S, Rosania GR, et al. 2013. Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver. Clin Pharmacol Ther. 94(1):126–141.
   PubMed Web of Science ®Google Scholar
• Fan J, de Lannoy IA. 2014. Pharmacokinetics. Biochem Pharmacol. 87(1):93–120.
   PubMed Web of Science ®Google Scholar
• Friden M, Bergstrom F, Wan H, Rehngren M, Ahlin G, Hammarlund-Udenaes M, Bredberg U. 2011. Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods. Drug Metab Dispos. 39(3):353–362.
   PubMed Web of Science ®Google Scholar
• Hallifax D, Houston JB. 2007. Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction. Drug Metab Dispos. 35(8):1325–1332.
   PubMed Web of Science ®Google Scholar
• Hann MM, Simpson GL. 2014. Intracellular drug concentration and disposition – the missing link? Methods. 68(2):283–285.
   PubMed Web of Science ®Google Scholar
• Harrison J, De Bruyn T, Darwich AS, Houston JB. 2018. Simultaneous assessment in vitro of transporter and metabolic processes in hepatic drug clearance: use of a media loss approach. Drug Metab Dispos. 46(4):405–414.
   PubMed Web of Science ®Google Scholar
• Hubatsch I, Ragnarsson EG, Artursson P. 2007. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc. 2(9):2111–2119.
   PubMed Web of Science ®Google Scholar
• Huth F, Domange N, Poller B, Vapurcuyan A, Durrwell A, Hanna ID, Faller B. 2021. Predicting oral absorption for compounds outside the rule of five property space. J Pharm Sci. 110(6):2562–2569.
   PubMed Web of Science ®Google Scholar
• Korjamo T, Heikkinen AT, Waltari P, Monkkonen J. 2008. The asymmetry of the unstirred water layer in permeability experiments. Pharm Res. 25(7):1714–1722.
   PubMed Web of Science ®Google Scholar
• Leeson P. 2012. Drug discovery: chemical beauty contest. Nature. 481(7382):455–456.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 46(1–3):3–26.
   PubMed Web of Science ®Google Scholar
• Mateus A, Gordon LJ, Wayne GJ, Almqvist H, Axelsson H, Seashore-Ludlow B, Treyer A, Matsson P, Lundback T, West A, et al. 2017. Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery. Proc Natl Acad Sci U S A. 114(30):E6231–e6239.
   PubMed Web of Science ®Google Scholar
• Mateus A, Matsson P, Artursson P. 2013. Rapid measurement of intracellular unbound drug concentrations. Mol Pharm. 10(6):2467–2478.
   PubMed Web of Science ®Google Scholar
• Ose A, Ito M, Kusuhara H, Yamatsugu K, Kanai M, Shibasaki M, Hosokawa M, Schuetz JD, Sugiyama Y. 2009. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4. ).Drug Metab Dispos. 37(2):315–321.
   PubMed Web of Science ®Google Scholar
• Overington JP, Al-Lazikani B, Hopkins AL. 2006. How many drug targets are there? Nat Rev Drug Discov. 5(12):993–996.
   PubMed Web of Science ®Google Scholar
• Riccardi K, Li Z, Brown JA, Gorgoglione MF, Niosi M, Gosset J, Huard K, Erion DM, Di L. 2016. Determination of unbound partition coefficient and in vitro-in vivo extrapolation for SLC13A transporter-mediated uptake. Drug Metabolism and Disposition: The Biological Fate of Chemicals. 44(10):1633–1642.
   PubMed Web of Science ®Google Scholar
• Riede J, Camenisch G, Huwyler J, Poller B. 2017. Current in vitro methods to determine hepatic Kpuu: a comparison of their usefulness and limitations. J Pharm Sci. 106(9):2805–2814.
   PubMed Web of Science ®Google Scholar
• Riede J, Umehara KI, Schweigler P, Huth F, Schiller H, Camenisch G, Poller B. 2019. Examining P-gp efflux kinetics guided by the BDDCS - rational selection of in vitro assay designs and mathematical models. Eur J Pharm Sci. 132:132–141.
   PubMed Web of Science ®Google Scholar
• Smith DA, Di L, Kerns EH. 2010. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov. 9(12):929–939.
   PubMed Web of Science ®Google Scholar
• Sugano K, Kansy M, Artursson P, Avdeef A, Bendels S, Di L, Ecker GF, Faller B, Fischer H, Gerebtzoff G, et al. 2010. Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov. 9(8):597–614.
   PubMed Web of Science ®Google Scholar
• Tatrai P, Schweigler P, Poller B, Domange N, de Wilde R, Hanna I, Gaborik Z, Huth F. 2019. A systematic in vitro investigation of the inhibitor preincubation effect on multiple classes of clinically relevant transporters. Drug Metab Dispos. 47(7):768–778.
   PubMed Web of Science ®Google Scholar
• Trainor GL. 2007. The importance of plasma protein binding in drug discovery. Expert Opin Drug Discov. 2(1):51–64.
   PubMed Web of Science ®Google Scholar
• Trünkle C, Lechner C, Korr D, Bouché L, Barak N, Fernández-Montalván A, Süssmuth RD, Reichel A. 2020. Concentration dependence of the unbound partition coefficient Kpuu and its application to correct for exposure-related discrepancies between biochemical and cellular potency of KAT6A inhibitors. Drug Metab Dispos. 48(7):553–562.
   PubMed Web of Science ®Google Scholar
• Vasta JD, Corona CR, Wilkinson J, Zimprich CA, Hartnett JR, Ingold MR, Zimmerman K, Machleidt T, Kirkland TA, Huwiler KG, et al. 2018. Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement. Cell Chem Biol. 25(2):206–214.e11.
   PubMed Web of Science ®Google Scholar
• Volpe DA. 2011. Drug-permeability and transporter assays in Caco-2 and MDCK cell lines. Future Med Chem. 3(16):2063–2077.
   PubMed Web of Science ®Google Scholar
• Wilkinson GR, Shand DG. 1975. Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 18(4):377–390.
   PubMed Web of Science ®Google Scholar
• Zhang D, Hop C, Patilea-Vrana G, Gampa G, Seneviratne HK, Unadkat JD, Kenny JR, Nagapudi K, Di L, Zhou L, et al. 2019. Drug concentration asymmetry in tissues and plasma for small molecule-related therapeutic modalities. Drug Metab Dispos. 47(10):1122–1135.
   PubMed Web of Science ®Google Scholar
• Zheng N, Tsai HN, Zhang X, Rosania GR. 2011. The subcellular distribution of small molecules: from pharmacokinetics to synthetic biology. Mol Pharm. 8(5):1619–1628.
   PubMed Web of Science ®Google Scholar